Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Indivior ( (GB:INDV) ) has provided an announcement.
Indivior PLC has announced the appointment of Joe Ciaffoni as the new Chief Executive Officer, succeeding Mark Crossley. Ciaffoni, with over 30 years of experience in the pharmaceutical and biotech industries, is expected to drive the next stage of growth for Indivior, a leader in addiction treatment. The transition is aimed at ensuring stability and continuity, with Ciaffoni’s leadership anticipated to enhance shareholder value and expand the company’s impact in the addiction treatment space.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat substance use disorders (SUD). The company aims to transform SUD from a global crisis into a recognized and treated chronic disease. Headquartered in Richmond, VA, Indivior employs over 1,000 individuals globally, offering a portfolio of products available in over 30 countries.
YTD Price Performance: -39.75%
Average Trading Volume: 297,606
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £767.8M
For a thorough assessment of INDV stock, go to TipRanks’ Stock Analysis page.